Company research / NEPH

Nephros Inc (NEPH)

SEC name NEPHROS INC · CIK 0001196298 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Nephros Inc reported revenue of $18.79M. Revenue grew 32.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $20.72M.

Key ratios (year ended 2025-12-31)

61.9%
Gross margin
6.1%
Operating margin
6.4%
Net margin
11.7%
Return on year-end equity
32.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$20.72M$18.79M$14.16M$14.24M$9.97M$10.22M$8.56M$10.33M$5.69M$3.81M$2.32M
Cost of Revenue$8.03M$7.16M$5.44M$5.83M$5.24M$4.58M$3.65M$4.25M$2.48M$1.52M$1.03M
Gross Profit$12.70M$11.62M$8.72M$8.40M$4.73M$5.63M$4.91M$6.08M$3.20M$2.29M$1.29M
R&D Expense$1.45M$1.34M$906.0K$873.0K$1.25M$1.50M$2.76M$3.09M$1.54M$1.00M$1.08M
Operating Income$1.64M$1.15M$6.0K-$1.59M-$4.33M-$3.25M-$4.28M-$3.15M-$3.02M-$2.23M-$2.87M
Depreciation & Amortization$124.0K$140.0K$135.0K$214.0K$218.0K$192.0K$192.0K$186.0K$163.0K$218.0K$230.0K
EBITDA$1.77M$1.29M$141.0K-$1.38M-$4.12M-$3.06M-$4.08M-$2.97M-$2.85M-$2.01M-$2.64M
Net Income$1.74M$1.19M$74.0K-$1.57Mn/a-$3.87M-$4.53M-$3.18M-$3.40M-$809.0K-$3.03M
EPS (Diluted)n/a$0.11$0.01-$0.15-$0.73n/an/an/an/an/an/a
Total Assets$15.77M$13.64M$11.21M$11.86M$11.00M$17.65M$18.51M$11.63M$10.56M$4.98M$2.68M
Total Liabilities$3.80M$3.44M$2.62M$3.50M$2.12M$2.90M$2.94M$3.94M$3.76M$3.03M$2.01M
Long-Term Debtn/an/an/an/a$71.0K$343.0K$593.0K$824.0K$1.04Mn/an/a
Shareholders' Equity$11.97M$10.20M$8.59M$8.36M$8.88M$14.75M$15.57M$7.69M$6.80M$1.95Mn/a
Cash & Equivalents$4.70M$5.40M$3.76M$4.31M$3.63M$6.97M$8.25M$4.17Mn/an/an/a
Operating Cash Flown/a$1.60M-$500.0Kn/an/an/an/an/an/a-$77.0K-$2.11M
Capital Expendituresn/an/a$55.0K$75.0K$137.0K$36.0K$239.0K$14.0Kn/an/a$45.0K
Free Cash Flown/an/a-$555.0Kn/an/an/an/an/an/an/a-$2.16M
Shares Outstanding10.86M10.64M10.54M10.54M10.30M10.26M9.87M8.06M7.18M55.29M49.78M
Weighted Average Diluted Sharesn/a10.97M10.60M10.39M10.30Mn/an/an/an/an/an/a
EPS (Basic)n/a$0.11$0.01-$0.15-$0.73-$0.41n/an/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView